Voyager Therapeutics, Inc. (BMV:VYGR)

Voyager Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	43.94	71.37	68.8	98.96	117.43	104.44
Short-Term Investments	171.65	195.32	162.07	19.89	15.11	76.7
Cash & Short-Term Investments	215.59	266.68	230.88	118.85	132.54	181.14
Cash Growth	-41.89%	15.51%	94.26%	-10.33%	-26.83%	-35.66%
Accounts Receivable	1.67	1.5	80.15	-	-	-
Other Receivables	0.85	0.68	3.34	0.26	0.73	8.01
Total Trade Receivables	2.53	2.18	83.49	0.26	0.73	8.01
Other Current Assets	9.77	7.95	5.32	5.39	3.43	8.62
Total Current Assets	227.89	276.81	319.68	124.5	136.7	197.77
Net Property, Plant & Equipment	44.89	47.66	30	33.34	55.38	61.5
Long-Term Investments	46.45	65.7	-	-	-	-
Other Long-Term Assets	2.87	2.87	1.59	1.52	1.78	2.32
Total Assets	322.1	393.05	351.28	159.36	193.86	261.58
Accounts Payable	1.8	4	1.6	2.57	0.57	0.63
Accrued Expenses	12.03	14.17	16.82	7.82	10.95	14.21
Current Portion of Leases	7.64	7.23	3.2	-	-	-
Unearned Revenue	20.52	24.39	42.88	59.38	33.89	7.73
Other Current Liabilities	-	-	-	2.83	5.57	4.2
Total Current Liabilities	41.98	49.79	64.51	72.59	50.98	26.77
Long-Term Leases	32.57	36.5	17.09	-	-	-
Other Long-Term Liabilities	3.61	7	33.36	27.75	47.82	80.5
Total Long-Term Liabilities	36.17	43.5	50.45	27.75	47.82	80.5
Total Liabilities	78.16	93.29	114.96	100.34	98.8	107.26
Common Stock	0.06	0.06	0.04	0.04	0.04	0.04
Additional Paid-in Capital	634.7	626.3	497.51	452.71	442.26	430.32
Accumulated Other Comprehensive Income	-0.22	-0.41	-0.05	-0.22	-0.14	-0.13
Retained Earnings	-390.59	-326.18	-261.18	-393.51	-347.1	-275.91
Shareholders' Equity	243.94	299.76	236.32	59.02	95.06	154.32
Total Liabilities & Equity	322.1	393.05	351.28	159.36	193.86	261.58
Total Debt	40.2	43.73	20.29	0	0	0
Net Cash (Debt)	175.39	222.96	210.58	118.85	132.54	181.14
Net Cash Growth	-21.34%	5.88%	77.19%	-10.33%	-26.83%	-35.66%
Net Cash Per Share	3.01	3.87	4.72	3.10	3.52	4.85
Book Value	243.94	299.76	236.32	59.02	95.06	154.32
Book Value Per Share	4.19	5.20	5.30	1.54	2.52	4.13
Tangible Book Value	243.94	299.76	236.32	59.02	95.06	154.32
Tangible Book Value Per Share	4.19	5.20	5.30	1.54	2.52	4.13

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.